Showing results (41-50 of 637) with videos related to
Sort By:
Pageof 64
Leukemia Research|November 15, 2000
Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patientsU Germing, N Gattermann, C Strupp, et al.Deutsche Medizinische Wochenschrift (1946)|September 13, 1996
[The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome]C Aul, U Germing, N Gattermann, et al.European Journal of Haematology|June 20, 2002
Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cellsM Aivado, A Rong, M Stadler, et al.Acta Haematologica|April 2, 2005
Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletionA A N Giagounidis, S Haase, U Germing, et al.Oncology Reports|May 20, 2011
Severe musculoskeletal pain after cyclosporin A treatment in a patient undergoing allogeneic BMTU Germing, D Sohngen, A Heyll, et al.Medizinische Klinik (Munich, Germany : 1983)|November 2, 1999
[Clinical course, morphology and prognosis of chronic myelomonocytic leukemia]U Germing, C Strupp, G Meckenstock, et al.Leukemia|November 1, 1994
Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf scoreC Aul, N Gattermann, U Germing, et al.Leukemia|January 1, 1992
Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring systemC Aul, N Gattermann, A Heyll, et al.European Journal of Medical Research|January 20, 1999
Pseudomonas aeruginosa orbital phlegmon in a patient treated for myelodysplastic syndrome with concomitant Sjögren's syndromeA A Giagounidis, A S Giagounidis, U Germing, et al.Cytotherapy|March 15, 2005
Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemiaG Kobbe, R Fenk, F Neumann, et al.Pageof 64